Richie Kohman, PhD, discusses in situ RNA sequencing and its emerging applications
Daniel E. Austin and Christopher C. Mulligan discuss the latest developments in portable mass spectrometers
Mary Jo Lamberti, PhD, discusses how AI is set to change the way data is handled and used in the pharmaceutical industry
Eric Denoyer, PhD, and Joe Hedrick discuss the latest developments in GC in this Q&A
Dr. Ronald J. Kendall is head of the Wildlife Toxicology Laboratory and professor of Environmental Toxicology in the Department of Environmental Toxicology at Texas Tech University
Khalid Shah, MS, PhD, is the director of the Center for Stem Cell Therapeutics and Imaging at Harvard Medical School and the Center of Excellence in Biomedicine at Brigham and Women’s Hospital (BWH).
Dr. Christopher Brown is a co-founder, VP, and CTO of 908 Devices Inc. (Boston, MA).
Carl Wittwer, PhD, talks to contributing editor Tanuja Koppal, PhD, about polymerase chain reaction (PCR)
How to overcome common challenges of validating methods and avoid delays
Associate editor Lauren Everett speaks with Dr. Mehdi Yazdi of SEQENS North America on the process of method validation in the pharma industry
Timothy Garrett, PhD, talks about the recent developments in mass spectrometry-based imaging and its growing applications, especially on the clinical side.
How recent advances in technology have helped bring cell therapies to the forefront
Andrea Ong is the lab manager of the Industrial Pharmacy Laboratory (IPhL) at the University
of the Sciences in Philadelphia, Pennsylvania.
Jared Auclair, PhD, talks about recent innovations and trends in biopharmaceutical analysis
Athula B. Attygalle is a faculty member in the Department of Chemistry and Chemical Biology at Stevens Institute of Technology in Hoboken, New Jersey.
Jeffrey Abels has more than 40 years of experience in lot sampling, inspection, grading,
Anthony Atala, MD, discusses some of the exciting possibilities as well as existing challenges in 3-D bioprinting